Genetic testing should be available for all breast cancer patients to determine hereditary risk in addition to standard imaging exams, according to new guidelines published Feb. 14 by The American Society of Breast Surgeons.
Some questions never seem to stop coming up. Should every single incidental finding be reported? If so, how so? In what sorts of cases might the reporting mislead clinicians rather than appropriately guide patient care? Here’s a fresh look at these perpetual concerns.
The rate of cancer incidence and deaths among African Americans has surpassed that of whites for decades, but recent data from the American Cancer Society suggests that the “cancer gap” is shrinking, according to a recent report from NPR.
Following radiation therapy for liver metastases, patients are just as well monitored with contrast-enhanced ultrasound as with contrast-enhanced CT, according to the authors of a pilot study running in the March edition of the Journal of Ultrasound in Medicine.
IBM Watson Health has announced a new 10-year, $50 million investment in joint research collaboration projects with Brigham and Women’s Hospital in Boston and Vanderbilt University Medical Center (VUMC) to advance the application of artificial intelligence (AI) in public health.
Digital breast tomosynthesis (DBT) leads to fewer false-positive (FP) recalls than full-field digital mammography (FFDM), according to new findings published in Academic Radiology. The patient’s age and the availability of prior mammograms were also important factors.
In radiology, hiring can sometimes be a time-consuming process. According to new research published in Current Problems in Diagnostic Radiology, the specialty could learn a thing or two about effective hiring techniques from innovative companies such as Google.
Exposure to dichlorodiphenyltrichloroethane (DDT) puts women at an increased risk of breast cancer through the age of 54, according to research published by the Journal of the National Cancer Institute.